FDA approves nation's 1st CRISPR gene therapy to treat sickle cell disease: Experts react

The FDA approved the nation's first medicine based on CRISPR gene-editing technology to treat patients with sickle cell disease, a major scientific advancement

Related Keywords

Boston ,Massachusetts ,United States ,Americans ,Eric Kmiec ,University Of Chicago Comer Children Hospital ,Boston Medical Center ,Vertex Pharmaceuticals ,Christiana Care Gene Editing Institute In Newark ,Christiana Care Gene Editing Institute ,Massachusetts General Hospital ,Comer Children ,Sickle Cell Disease ,Rispr ,Gene Editing ,Fda Approved ,Casgevy ,Crispr Therapeutics ,Gene Therapy ,Lyfgenia ,Bluebird Bio ,